Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376. https://doi.org/10.1093/jnci/85.5.365
Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J et al (2021) Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterol Hepatol 6(2):92–105. https://doi.org/10.1016/S2468-1253(20)30333-2
Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EMK et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22(1):29–42. https://doi.org/10.1016/S1470-2045(20)30555-6
Baird P, Steinke JD, Minnaar HS, Stewart AJ (2023) Assessment of quality of life in rectal cancer with organ-preservation treatment: are we there yet? Clin Oncol (r Coll Radiol) 35(2):e110–e120. https://doi.org/10.1016/j.clon.2022.11.002
Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM et al (2018) Feasibility of implementing the patient-reported outcomes version of the common terminology criteria for adverse events in a multicenter trial: NCCTG N1048. J Clin Oncol 36(31):3120–3125. https://doi.org/10.1200/jco.2018.78.8620
Article PubMed Central Google Scholar
Basch E, Dueck AC, Mitchell SA, Mamon H, Weiser M, Saltz L et al (2023) Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048). J Clin Oncol 41(21):3724–3734. https://doi.org/10.1200/jco.23.00903
Article PubMed PubMed Central Google Scholar
Burch J, Taylor C, Wilson A, Norton C (2021) Symptoms affecting quality of life after sphincter-saving rectal cancer surgery: a systematic review. Eur J Oncol Nurs 52:101934. https://doi.org/10.1016/j.ejon.2021.101934
Cersosimo RJ (2005) Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39(1):128–135. https://doi.org/10.1345/aph.1E319
Conroy T, Bosset J-F, Etienne P-L, Rio E, François É, Mesgouez-Nebout N et al (2021) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(5):702–715. https://doi.org/10.1016/S1470-2045(21)00079-6
Donnelly M, Ryan OK, Ryan ÉJ, Creavin B, O’Reilly M, McDermott R et al (2023) Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials. BJS 110(10):1316–1330. https://doi.org/10.1093/bjs/znad177
Downing A, Glaser AW, Finan PJ, Wright P, Thomas JD, Gilbert A et al (2019) Functional outcomes and health-related quality of life after curative treatment for rectal cancer: a population-level study in England. Int J Radiat Oncol Biol Phys 103(5):1132–1142. https://doi.org/10.1016/j.ijrobp.2018.12.005
Fabian A, Rühle A, Liegl G, Domschikowski J, Trommer M, Ferdinandus S et al (2025) Quality of life in cancer patients at the end of radiotherapy compared to a general population sample in Germany. Int J Cancer. https://doi.org/10.1002/ijc.70152
Article PubMed PubMed Central Google Scholar
Fayers P, Aaronson NK, Bjordal K, Grønvold M, Curran D, Bottomley A (2001) EORTC QLQ-C30 scoring manual. European Organisation for research and treatment of cancer
Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R et al (2019) Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. J Clin Oncol 37(34):3212–3222. https://doi.org/10.1200/jco.19.00308
Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R et al (2022) Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial. JAMA Oncol 8(1):e215445-e. https://doi.org/10.1001/jamaoncol.2021.5445
Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM et al (2022) Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 40(23):2546–2556. https://doi.org/10.1200/jco.22.00032
Article PubMed PubMed Central Google Scholar
Giandomenico F, Gavaruzzi T, Lotto L, Del Bianco P, Barina A, Perin A et al (2015) Quality of life after surgery for rectal cancer: a systematic review of comparisons with the general population. Expert Rev Gastroenterol Hepatol 9(9):1227–1242
Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW et al (2016) Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol 69:79–88. https://doi.org/10.1016/j.jclinepi.2015.08.007
Gilbert A, Ziegler L, Martland M, Davidson S, Efficace F, Sebag-Montefiore D et al (2015) Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: a comparison of patient-reported outcomes and clinician toxicity reporting. Int J Radiat Oncol Biol Phys 92(3):555–567. https://doi.org/10.1016/j.ijrobp.2015.02.021
Gilbert A, Homer V, Brock K, Korsgen S, Geh I, Hill J et al (2022) Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision. Lancet Healthy Longevity 3(12):e825–e838. https://doi.org/10.1016/S2666-7568(22)00239-2
Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rodel C, Cervantes A et al (2017) Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(4):iv22–iv40. https://doi.org/10.1093/annonc/mdx224
Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KNL et al (2007) Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer 43(10):1564–1573. https://doi.org/10.1016/j.ejca.2007.04.005
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. https://doi.org/10.1016/j.jbi.2008.08.010
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208. https://doi.org/10.1016/j.jbi.2019.103208
Article PubMed PubMed Central Google Scholar
Hinz A, Singer S, Brähler E (2014) European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol 53(7):958–965. https://doi.org/10.3109/0284186X.2013.879998
Hinz A, Mehnert A, Dégi C, Reissmann DR, Schotte D, Schulte T (2017) The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients. Eur J Cancer Care (Engl). https://doi.org/10.1111/ecc.12416
Ho VP, Lee Y, Stein SL, Temple LKF (2011) Sexual function after treatment for rectal cancer: a review. Dis Colon Rectum 54(1):113–125. https://doi.org/10.1007/DCR.0b013e3181fb7b82
JASP Team. JASP (Version 0.19.3). 0.19.3 ed. Amsterdam, The Netherlands
Jones HJS, Al-Najami I, Cunningham C (2020) Quality of life after rectal-preserving treatment of rectal cancer. Eur J Surg Oncol 46(11):2050–2056. https://doi.org/10.1016/j.ejso.2020.07.018
Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes HS, Jahn P et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 31(10):1306–1319. https://doi.org/10.1016/j.annonc.2020.07.003
Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J et al (2020) Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw Open 3(12):e2030097-e. https://doi.org/10.1001/jamanetworkopen.2020.30097
Comments (0)